Telomir Pharmaceuticals (TELO)
Develops an oral small-molecule candidate for advanced triple-negative breast cancer.
$1.22
vs last close−0.03 (−2.40%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 4.31% | 2.97M shares | |
|---|---|---|---|
| 32 holders · as of Jun 30, 2026 | |||
| Insiders | 10.64% | 7.32M shares | |
| 1 holder · as of Apr 24, 2026 | |||
| Strategic holders | 5.12% | 3.52M shares | |
| 1 holder · as of Oct 3, 2025 | |||
| Other | 79.93% | 54.97M shares | |
| remainder | |||
68.77M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
32 holders · 2.97M shares · 10 new positions · 16 increased · 3 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 1.61M | 2.35% | +618.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 338.9K | 0.49% | +89.8K | Aug 12, 2026 |
| BlackRock, Inc. | 280.5K | 0.41% | −8.7K | Aug 7, 2026 |
| Vanguard Fiduciary Trust Co | 225.3K | 0.33% | +89.8K | Aug 13, 2026 |
| Northern Trust Corp | 61.5K | 0.09% | +19.7K | Aug 13, 2026 |
| State Street Corp | 58.6K | 0.09% | 0 | Aug 7, 2026 |
| Bank of New York Mellon Corp | 51.5K | 0.07% | 0 | Aug 6, 2026 |
| Captrust Financial Advisors | 51.2K | 0.07% | +51.2Knew | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity | 9.44% | 3.25M | 13G | Feb 12, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.